Drug profile · INN
repository corticotropin
H.P. ACTHAR GEL
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
repository corticotropin (H.P. ACTHAR GEL) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
Key facts
INN repository corticotropin
Brand H.P. ACTHAR GEL
Route INJECTION
Formulation INJECTABLE
Frequently asked questions
What is repository corticotropin?
repository corticotropin (H.P. ACTHAR GEL) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for repository corticotropin?
H.P. ACTHAR GEL is a marketed brand name for repository corticotropin. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of repository corticotropin?
repository corticotropin has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.